Julie O'Neill
2016
In 2016, Julie O'Neill earned a total compensation of $4.1M as Former Executive Vice President of Global Operations at Alexion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $357,000 |
|---|---|
| Option Awards | $1,302,919 |
| Salary | $509,023 |
| Stock Awards | $1,716,538 |
| Other | $213,443 |
| Total | $4,098,923 |
O'Neill received $1.7M in stock awards, accounting for 42% of the total pay in 2016.
O'Neill also received $357K in non-equity incentive plan, $1.3M in option awards, $509K in salary and $213.4K in other compensation.
Rankings
In 2016, Julie O'Neill's compensation ranked 2,152nd out of 14,075 executives tracked by ExecPay. In other words, O'Neill earned more than 84.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,152 out of 14,075 | 85th |
Division Manufacturing | 744 out of 5,486 | 86th |
Major group Chemicals And Allied Products | 219 out of 1,900 | 89th |
Industry group Drugs | 158 out of 1,543 | 90th |
Industry Pharmaceutical Preparations | 125 out of 1,173 | 89th |
Source: SEC filing on March 26, 2019.